<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <article-meta>
      <title-group>
        <article-title>Neurodegenerative and depressive disorders - Lead from Herbals</article-title>
      </title-group>
      <contrib-group content-type="author">
        <contrib contrib-type="person">
          <name>
            <given-names>M.U. Jiji Mohan</given-names>
          </name>
          <email>jiji.mohan450@gmail.com</email>
          <xref ref-type="aff" rid="aff-1"/>
        </contrib>
      </contrib-group>
      <aff id="aff-1">
        <institution>Department of Pharmacognosy, Periyar College of Pharmaceutical Sciences, Tiruchirappalli – 620021, Tamil Nadu, India.</institution>
        <country>India</country>
      </aff>
      <history>
        <date date-type="received" iso-8601-date="2020-08-14">
          <day>14</day>
          <month>08</month>
          <year>2020</year>
        </date>
        <date data-type="published" iso-8601-date="2020-08-14">
          <day>14</day>
          <month>08</month>
          <year>2020</year>
        </date>
      </history>
    </article-meta>
  </front>
  <body>
    <fig>
      <graphic mimetype="image" mime-subtype="jpeg" xlink:href="image1.jpeg"/>
    </fig>
    <p>
      <bold>www.ijamscr.com</bold>
    </p>
    <sec id="sec-1">
      <title>Neurodegenerative and depressive disorders - Lead from Herbals</title>
      <sec id="sec-1_1">
        <title>M.U. Jiji Mohan*, R. Senthamarai, T. Shri Vijaya Kirubha, V. Arun Nivas, V. Selvakumari, K.S Pragathi</title>
        <p>
          <italic>Department of </italic>
          <italic>Pharmacognosy</italic>
          <italic>, </italic>
          <italic>Periyar</italic>
          <italic> College of Pharmaceutical Sciences, </italic>
          <italic>Tiruchirappalli</italic>
          <italic> – 620021, </italic>
        </p>
        <p>
          <italic>Tamil Nadu, India.</italic>
        </p>
        <p><bold>*Corresponding Author</bold>:<bold>M.U. </bold><bold>Jiji</bold><bold> Mohan</bold></p>
        <p>
          <bold>Email id: </bold>
          <bold>jiji.mohan450@gmail.com</bold>
        </p>
        <sec id="sec-1_1_1">
          <title>ABSTRACT</title>
          <p>Neurodegenerative disorders are the condition characterized by destruction in neuronal cells, abruption of neuronal activity and distinct involvement of the functional movement. It includes disorders such as Alzheimer's disease, Parkinson's disease, Schizophrenia, Epilepsy, Depression and Anxiety which pose a sizable global health problem, accompanying substantial burden of disorder, suicides, physical co morbidities, high fiscal expenses and poor quality of life. There is a recent upsurge in global interest towards the area of traditional therapies and phytomedicines are widely admired by researcher's owing to their natural source and fewer side effects. Herbal medicines provides several nootropic herbs having multidimensional bioactivities in various neurodegenerative and depressive disorders. Scattered information is available pertaining to traditional herbal remedial options for various mental disorders. Studies on the lead molecules from herbals for neurodegenerative and depressive disorders would be a better option and it opens up for future investigation and standardization on herbal nootropic herbs. With these considerations, the present topic has been aimed to discuss the significance of herbals in the treatment of neurodegenerative and depressive disorders.</p>
          <p>Keywords: Lead molecules, Neurodegenerative disorders, Nootropic herbs, Phytomedicines.</p>
        </sec>
        <sec id="sec-1_1_2"/>
        <sec id="sec-1_1_3">
          <title>Introduction</title>
          <p>Natural products are the best source for the discovery of new drugs. About 80% drug molecules are natural products or derived from natural compounds. The natural products or naturally derived drugs may be used in treatment of many major diseases such as cancer, cardiovascular diseases and neurodegenerative diseases. Natural products played a significant role in the management of neurodegenerative disorders with numerous discovery of drugs for psychosis, depression, anxiety, Parkinson’s disease (PD), Alzheimer’s disease (AD), etc. In drug discovery a lead compound is a chemical compound   that has pharmacological or biological activity that is likely to be therapeutically useful. It is the chemical structure that serves as a starting point for chemical modifications in order to improve potency, selectivity or pharmacokinetic parameters. There are many natural products which are used as lead point for the development of new drugs for the treatment of neurodegenerative and depressive disorders and some important medicinal plants reported are <italic>Withania</italic><italic>somnifera</italic>, <italic>Bacopa</italic><italic>monnieri</italic><italic>, </italic><italic>Centella</italic><italic>asiatica</italic><italic>, </italic><italic>Mucuna</italic><italic>pruriens</italic>,<italic>Abrus</italic><italic>precatorius</italic><italic>, </italic><italic>Acorus</italic><italic>calamus</italic><italic>, </italic><italic>Adhatoda</italic><italic>vasica</italic><italic>, </italic><italic>Mentha</italic><italic>spicata</italic><italic>, Piper </italic><italic>nigrum</italic><italic>, </italic><italic>Emblica</italic><italic>officinalis</italic>etc.</p>
          <sec id="sec-1_1_3_1">
            <title>Neurodegenerative disorders</title>
            <p>It is a term for a range of conditions which primarily affect the neurons in the human brain. Neurons are the building blocks of the nervous system which includes the brain and spinal cord. Neurons normally do not reproduce or replace themselves, so when they become damaged or die they cannot be replaced by the body. Neurodegenerative diseases are incurable and debilitating conditions that results in progressive degeneration or   death of nerve cells. This causes problems with movement (called ataxias) or mental functioning (called dementias). Some examples of neurodegenerative drugs from plant sources are given in Table no 1.</p>
            <p>
              <bold>Table-1:  List of neurodegenerative drugs from Plant sources</bold>
            </p>
            <table-wrap>
              <table>
                <tr>
                  <td>
                    <bold>Plant name</bold>
                  </td>
                  <td>
                    <bold>Active compounds</bold>
                  </td>
                  <td>
                    <bold>Disorder</bold>
                  </td>
                </tr>
                <tr>
                  <td>
                    <italic>Adhatoda</italic>
                    <italic>vasica</italic>
                  </td>
                  <td>Vasicine, vasicol, vasicinol, arachidic, linoleic,and oleic acids</td>
                  <td>AD, PD</td>
                </tr>
                <tr>
                  <td>
                    <italic>Ginkgo </italic>
                    <italic>biloba</italic>
                  </td>
                  <td>Amentoflavone</td>
                  <td>PD</td>
                </tr>
                <tr>
                  <td>
                    <italic>Centella</italic>
                    <italic>asiatica</italic>
                  </td>
                  <td>Asiaticoside</td>
                  <td>Schizophrenia</td>
                </tr>
                <tr>
                  <td>
                    <italic>Panax</italic>
                    <italic> ginseng</italic>
                  </td>
                  <td>Ginsenoside</td>
                  <td>PD</td>
                </tr>
                <tr>
                  <td>
                    <italic>Rauwolfia</italic>
                    <italic>serpentina</italic>
                  </td>
                  <td>Reserpine</td>
                  <td>Schizophrenia</td>
                </tr>
                <tr>
                  <td>
                    <italic>Withania</italic>
                    <italic>somnifera</italic>
                  </td>
                  <td>Withaferine, sitoindoside, physagualinD, viscosalactone</td>
                  <td>Schizophrenia</td>
                </tr>
              </table>
            </table-wrap>
            <p><bold>AD – </bold>Alzheimer’s disease , <bold>PD – </bold>Parkinson’s disease</p>
            <p>
              <bold>Figure.1 shows the various biological mechanisms contributing to neurodegenerative disorders</bold>
            </p>
          </sec>
          <sec id="sec-1_1_3_2"/>
          <sec id="sec-1_1_3_3">
            <title>Lead compound</title>
            <p>A lead compound in drug discovery is a chemical compound that has pharmacological or biological activity likely to be therapeutically useful, but may nevertheless have suboptimal structure that require modification to fit better to the target; lead drug offer the prospect of being followed by back-up compounds. Its chemical structure serves as a starting point for chemical modifications in order to improve potency, selectivity or pharmacokinetic parameters. Now a days the lead drugs are developed from herbals for many disease conditions due to their safety and efficacy. For the treatment of neurodegenerative disorders   many natural drugs are available, and from this natural sources new efficient drugs are developed by using the natural products as a lead structure. Some examples of such compounds are listed in the Table 2.</p>
            <p>
              <bold>Table-2: </bold>
              <bold>List of lead</bold>
              <bold> compounds </bold>
              <bold>from natural sources</bold>
            </p>
            <table-wrap>
              <table>
                <tr>
                  <td>
                    <bold>Lead compound</bold>
                  </td>
                  <td>
                    <bold>Natural source</bold>
                  </td>
                  <td>
                    <bold>Family</bold>
                  </td>
                  <td>
                    <bold>Use</bold>
                  </td>
                </tr>
                <tr>
                  <td>Cyclosporine A</td>
                  <td>
                    <italic>Tolypocladium</italic>
                    <italic>inflatum</italic>
                  </td>
                  <td>Ophiocordycipitaceae</td>
                  <td>Reduction in neuron cell death</td>
                </tr>
                <tr>
                  <td>Huperzine A</td>
                  <td>
                    <italic>Huperzia</italic>
                    <italic> serrate</italic>
                  </td>
                  <td>Lycopodiaceae</td>
                  <td>Memory loss, AD</td>
                </tr>
                <tr>
                  <td>Curcumin</td>
                  <td>
                    <italic>Curcuma longa</italic>
                  </td>
                  <td>Zingiberaceae</td>
                  <td>Dementia, AD</td>
                </tr>
                <tr>
                  <td>Bryostatin-1</td>
                  <td>
                    <italic>Bugula</italic>
                    <italic>neritina</italic>
                  </td>
                  <td>Bugulidae</td>
                  <td>Memory enhancing agent, AD</td>
                </tr>
                <tr>
                  <td>Resveratrol</td>
                  <td>
                    <italic>Vitis</italic>
                    <italic>vinifera</italic>
                  </td>
                  <td>Vitacea</td>
                  <td>Antioxidant, AD, Amyotrophic lateral sclerosis</td>
                </tr>
                <tr>
                  <td>Rifampicin</td>
                  <td>
                    <italic>Amycolatopsis</italic>
                    <italic>rifamycinia</italic>
                  </td>
                  <td>Pseudonocardiaceae</td>
                  <td>AD</td>
                </tr>
              </table>
            </table-wrap>
          </sec>
        </sec>
        <sec id="sec-1_1_4"/>
        <sec id="sec-1_1_5">
          <title>Conclusion</title>
          <p>Plant derived bioactive compounds in addition of directly being developed as drugs also serve as prototype drug molecule known as lead compounds. This may help in better understanding of pharmacological and biochemical mechanisms. The majority of neurodegenerative agents are primarily from plants, animals, marine and microbial sources. The natural molecules are subjected to chemical derivatisation and synthesis of analogues for better efficacy and pharmacokinetic properties. Thus natural products have emerged as promising hope in the drug discovery programme in neurodegenerative disorders. In future, phytochemicals could be used as promising therapeutic agent for neurodegenerative disorders due to their anti-inflammatory as well as anticholinesterase activities. Thus phytochemicals may serve as promising alternatives to current therapies for neurodegenerative disorders.</p>
        </sec>
        <sec id="sec-1_1_6">
          <title>References</title>
          <list list-type="bullet">
            <list-item>
              <p>Rohit Sharma, Atul Kabra, M.MRao, P.K Prajapati. Herbal and Holistic Solutions for Neurodegenerative and Depressive Disorders: Leads From Ayurveda Review. Current Pharmaceutical Design, 24(22), 2018, 2597- 2602.</p>
            </list-item>
            <list-item>
              <p>Rohit Sharma, Atul Kabra, Uttam Singh Baghel, Hetal Amin, Herbal Solution For Neuropsychiatric and Neurodegenerative Disorders, WJPRT, 4(5), 2016, 1-3.</p>
            </list-item>
            <list-item>
              <p>Babitha K Vazhayil, R Shanmuga Sundaram,V M Annapandian, B R Abhirama, M Sudha, T Thiyagarajan, K Gladys Kalpana and S Pushpa: Natural Product and its Derived Drugs for the Treatment of Neurodegenerative Disorders: Alzheimer’s Disease- A Review. British Biomedical Bulletin, 2(2), 2014, 359-370.</p>
            </list-item>
            <list-item>
              <p>Claudio Viegas Jr, Helineide Cristina Campos, Miguel Divino da Rocha, Flavia Pereira Dias Viegas, Patricia Carolina Nicastro, Poliana Calve Fossaluzza, Carlos Alberto Manssour Fraga, Eliezer J. Barreiro, The role of natural products in the discovery of new drug Candidates for the Treatment of Neurodegenerative Disorders I: Parkinson’s Disease Review. CNS Neurol Disorder Drug Targets, 10(2), 2011, 239-250.</p>
            </list-item>
            <list-item>
              <p><ext-link xlink:href="javascript:ShowAffiliation('0','8')">Miguel </ext-link><ext-link xlink:href="javascript:ShowAffiliation('0','8')"></ext-link><ext-link xlink:href="javascript:ShowAffiliation('0','8')">Divino</ext-link><ext-link xlink:href="javascript:ShowAffiliation('0','8')"></ext-link><ext-link xlink:href="javascript:ShowAffiliation('0','8')"> da Rocha</ext-link>, Flavia Pereira Dias Viegas, Helineide Cristina Campos, <ext-link xlink:href="javascript:ShowAffiliation('3','8')">Patricia Carolina </ext-link><ext-link xlink:href="javascript:ShowAffiliation('3','8')"></ext-link><ext-link xlink:href="javascript:ShowAffiliation('3','8')">Nicastro</ext-link><ext-link xlink:href="javascript:ShowAffiliation('3','8')"></ext-link>, Poliana Calve Fossaluzza, <ext-link xlink:href="javascript:ShowAffiliation('5','8')">Carlos Alberto </ext-link><ext-link xlink:href="javascript:ShowAffiliation('5','8')"></ext-link><ext-link xlink:href="javascript:ShowAffiliation('5','8')">Manssour</ext-link><ext-link xlink:href="javascript:ShowAffiliation('5','8')"></ext-link><ext-link xlink:href="javascript:ShowAffiliation('5','8')"> </ext-link><ext-link xlink:href="javascript:ShowAffiliation('5','8')"></ext-link><ext-link xlink:href="javascript:ShowAffiliation('5','8')">Fraga</ext-link><ext-link xlink:href="javascript:ShowAffiliation('5','8')"></ext-link>, Eliezer J. Barreiro, <ext-link xlink:href="javascript:ShowAffiliation('7','8')">Claudio </ext-link><ext-link xlink:href="javascript:ShowAffiliation('7','8')"></ext-link><ext-link xlink:href="javascript:ShowAffiliation('7','8')">Viegas</ext-link><ext-link xlink:href="javascript:ShowAffiliation('7','8')"></ext-link>, The Role of Natural Products in the Discovery of New Drug Candidates for the Treatment of Neurodegenerative Disorders II: Alzheimers Disease <bold>:</bold> CNS &amp; Neurological Disorders - Drug Targets 10(2), 2011,  251-270.</p>
            </list-item>
            <list-item>
              <p>Subhash C. Lakhotia, Neurodegeneration disorders need holistic care and treatment – can ayurveda meet the challenge?  Annals of neurosciences, 20(1), 2013, 1-2.</p>
            </list-item>
            <list-item>
              <p>Franziska Pohl and Paul Kong Thoo Lin,   The Potential Use of Plant Natural Products and Plant Extracts with Antioxidant Properties for the Prevention/Treatment of Neurodegenerative Diseases: In Vitro, In Vivo and Clinical Trials- A review, 23, 2018, 3283.</p>
            </list-item>
            <list-item>
              <p>Parul Agarwal, Shashi Alok, Amreen Fatima and Prem Prakash Singh, Herbal remedies for neurodegenerative disorder (alzheimer's disease): a review, IJPSR, 4(9), 2013, 3328-3340.</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </sec>
  </body>
  <back/>
</article>
